Novartis CEO Warns Trump’s Drug Pricing Policy Creates Major Challenge
Novartis Chief Executive Vas Narasimhan warned on Tuesday that U.S. Drug pricing policies under the Trump administration have created a “very demanding situation” for the pharmaceutical industry, signaling growing tensions ... Read More